Iodine 131 and differentiated thyroid carcinoma;Iode 131 et cancers thyroidiens differencies

Annales d'Endocrinologie

Volumn 57, Issue 3, 1996, Pages 186-193

  Delisle, M J ^a   Schvartz, C ^a  

^a INSTITUT JEAN GODINOT   (France)

Author keywords

131I radioiodine; differentiated thyroid carcinoma

Indexed keywords

IODINE 131; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; THYROGLOBULIN;

CONFERENCE PAPER; HUMAN; METASTASIS; THYROID CARCINOMA; ADULT; FEMALE; MALE; POSTOPERATIVE PERIOD; REVIEW; SCINTISCANNING; THYROID TUMOR; THYROIDECTOMY;

ADULT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; NEOPLASM METASTASIS; POSTOPERATIVE PERIOD; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0029742966     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. BYAR DP, GREEN SB, DOR P et al. Prognostic Index for Thyroid Carcinoma. A Study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 1979 ; 15 : 1033-41
2. CADY B, ROSSI R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988 ; 104 : 947-53.
3. CASARA D, RUBELLO D, SALADINI G et al. Different Features of Pulmonary Metastases in Differentiated Thyroid Cancer : Natural History and Multivariate Statistical Analysis of Prognostic Variables. J Nucl Med 1993 ; 34 : 1626-31.
4. CULVER CM, DWORKIN HJ. Radiation Safety Considerations for Post-Iodine-131 Thyroid Cancer Therapy. J Nucl Med 1992 ; 33 : 1402-5.
5. DELISLE MJ, GIBOLD C, SCHLUMBERGER M. Treatment of Thyroid Cancer with 131-I in Europe Eur J Nucl Med 1990; 16: S 70.
6. DELISLE MJ. La radioprotection des malades, de leur entourage et de leur environnement lors de l'utilisation thérapeutique des sources radioactives non scellées (Personnel médical exclu). In : Radioprotection et Santé Publique, Ed ; ACOMEN, Lyon, 1993 ; pp. 151-160.
7. DIRUSSO G, KERN KA. Comparative analysis of complications from I-131 radioablation for well-differentiated thyroid cancer. Surgery 1994 , 116 : 1024-30.
8. FRANCESCHI S, BOYLE P, MAISONNEUVE P et al. The Epidemiology of Thyroid Carcinoma. Critical Reviews in Oncogenesis 1993 ; 4 . 25-52.
9. GIBOLD C, DELISLE MJ, LIEHN JC. Usefulness of bone anatomic landmarking in 131 iodine scan for the diagnosis of metastases of differentiated thyroid carcinoma In : Schmidt HAE, van der Schoot JB, eds. Nuclear medicine. Stuttgart New York : Schattauer 1991 ; 46-8.
10. HANNEQUIN P, LIEHN JC, DELISLE MJ. Multifactorial Analysis of Survival in Thyroid Cancer. Pitfalls of Applying the Results of Published Studies to Another Population. Cancer 1986 ; 58 : 1749-55.
11. HAY ID, BERGSTRALH EJ, GOELLNER JR, EBERSOLD JR, GRANT CS. Predicting outcome in papillary thyroid carcinoma : Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993 ; 114 : 1050-8.
12. HAY ID. Prognostic Factors in Thyroid Carcinoma. Thyroid Today 1989 ; 11 : 1-9
13. MAXON HR. The Role of 131I in the Treatment of Thyroid Cancer. Thyroid Today 1993 ; 2 : 1-9.
14. MAZZAFERRI EL, JUIANG SM. Long-term Impact of Initial Surgical and Medical Therapy on Papillary and Follicular Thyroid Cancer. Am J Nucl 1994 ; 97 . 418-28.
15. MAZZAFERRI EL. Treating High Thyroglobulin with Radioiodine : a Magic Bullet or a Shot in the Dark ? JCEM 1995 ; 80 : 1485-7.
16. PACINI F, CETANI F, MICCOLI P et al. Outcome of 309 Patients with Metastatic Differentiated Thyroid Carcinoma Treated with Radioiodine. World J Surg 1994 ; 600-4.
17. PACINI F, LIPPI F, FORMICA N et al. Therapeutic Doses of Iodine-131 Reveal Undiagnosed Metastases in Thyroid Cancer Patients with Detectable Serum Thyroglobulin Levels. J Nucl Med 1987 ; 28 : 1888-91.
18. PINEDA JD, LEE T, AIN K, REYNOLDS JC, ROBBINS J. Iodine-131 Therapy for Thyroid Cancer Patients with Elevated Thyroglobulin and Negative Diagnostic Scan. J Clin Endocrinol Metab 1995 ; 80 : 1488-92.
19. PINEDA JD, LEE T, ROBBINS J. Treating Metastatic Thyroid Cancer. The Endocrinologist 1993 ; 3 : 433-42.
20. RUEGEMER JJ, HAY ID, BERGSTRALH EJ et al. Distant Metastases in Differentiated Thyroid Carcinoma : a Multivariate Analysis of prognostic Variables. J Clin Endocrinol Metab 1988 ; 67 : 501-80
21. SAMAAN NA, MAHESHWARI K, NADER S et al. Impact of Therapy for Differentiated Carcinoma of the Thyroid : An Analysis of 706 Cases. Endocrinol Metab 1983 ; 56 : 1131-7.
22. SAMUEL AM, UNNIKRISHNAN TP, BAGHEL NS, RAMSHEKHARRAO B. Effect of Radioiodine therapy on Pulmonary Alveolar-Capillary Membrane Integrity. J Nucl Med 1995 ; 36 : 783-7.
23. SCHELFHOUT LJ, CREUTZBERG CL, HAMMING JF et al. Multivariate Analysis of Survival in Differentiated Thyroid Cancer : the Prognostic Significance of the Age Factor. Eur J Cancer Clin Oncol 1988 ; 24 : 331-7.
24. SCHLUMBERGER M ARCANGIOLI O, PIERKARSKI JD, TUBIANA M, PARMENTIER C. Detection and Treatment of Lung Metastases of Differentiated Thyroid Carcinoma in Patient with Normal Chest X-Rays. J Nucl Med 1988 ; 29 : 1790-4.
25. SCHLUMBERGER M, DE VATHAIRE F, CECCARELLI C et al. Exposure to radioactive iodine (I-131) for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients (à paraître).
26. SCHLUMBERGER M, TUBIANA M, DE VATHAIRE F et al. Long-Term Results of Treatment of 283 Patients with Lung and bone Metastases from Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab 1986 , 63 : 960-7
27. SCOTT AM, MACAPINLAC HM, ZHANG J et al. Image Registration of SPECT and CT Images Using an External Fiduciary Band and three-Dimensional Surface Fitting in Metastatic Thyroid Cancer. J Nucl Med 1995 , 36 : 100-3
28. TENENBAUM F, LUMBROSO J, SCHLUMBERGER M, CAILLOU B, FRAGU P, PARMENTIER C. Radiolabeled somatostatin analog scintigraphy in differentiated carcinoma J Nucl Med 1995 ; 36 : 807-10.
29. TENENBAUM F, SCHLUMBERGER M, BONNIN F et al. Usefulness of technetium-99m hydroxymethylene disphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma. Eur J Nucl Med 1993 ; 20 : 1168-74.
30. TUBIANA M, SCHLUMBERGER M, ROUGIER P et al. Long-Term Results and Prognostic Factors in Patients With Differentiated Thyroid Carcinoma. Cancer 1985 ; 55 : 794-804.